-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Aspirin (acetylsalicylic acid) is one of the three oldest and most widely used classic drugs in the world
In 1897, Bayer, Germany, synthesized the main substances constituting aspirin for the first time, which promoted the marketing of the drug.
In 1988, Australian scholars first proposed that aspirin can prevent cancer.
Recently, a research team from Cardiff University in the United Kingdom published an article titled Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers in eCancerMedicalScience.
The researchers conducted a systematic retrospective analysis of 118 observational studies covering 18 different types of cancer patients
Although aspirin is a "magic medicine", any kind of drug can not avoid the side effects.
The study found that a small number of patients had bleeding, but there is no evidence that patients taking aspirin died due to excessive bleeding
The association between aspirin use and mortality
Note: The original text has been deleted
Reference materials:
[1]https://doi.